Treatment resistance · children diagnosed with Kawasaki disease
TNF‐α blockers intervention may leads to lower treatment resistance compared with placebo or additional treatment (low certainty).
1 finding from 1 review
Incidence of coronary artery abnormalities · children diagnosed with Kawasaki disease
TNF‐α blockers intervention showed no clear difference in incidence of coronary artery abnormalities compared with placebo or additional treatment (low certainty).
1 finding from 1 review
Infusion reactions · children diagnosed with Kawasaki disease
TNF‐α blockers intervention may leads to lower adverse effects after treatment initiation: infusion reactions compared with placebo or additional treatment (low certainty).
1 finding from 1 review
Adverse effects after treatment initiation: infections · children diagnosed with Kawasaki disease
TNF‐α blockers intervention showed no clear difference in adverse effects after treatment initiation: infections compared with placebo or additional treatment (low certainty).
1 finding from 1 review
Rash · children diagnosed with Kawasaki disease
It is very uncertain whether TNF‐α blockers intervention changes adverse effects after treatment initiation: cutaneous reactions (rash) compared with placebo or additional treatment (very low certainty).
1 finding from 1 review
Adverse effects: contact dermatitis · children diagnosed with Kawasaki disease
It is very uncertain whether TNF‐α blockers intervention changes adverse effects after treatment initiation: cutaneous reactions… compared with placebo or additional treatment (very low certainty).
1 finding from 1 review
Adverse effects after treatment initiation: injection site reactions, neutropenia, infections, demyelinating disease, heart failure, malignancy, and induction of autoimmunity. · children diagnosed with Kawasaki disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found